Profil
Brent J.
Warner is currently Chief Executive Officer & Director at Protego Biopharma, Inc. since 2024.
Formerly, Mr. Warner was President-Gene Therapy at Poseida Therapeutics, Inc. from 2022 to 2024 and Vice President-Gene Therapy & Rare Disease at Novartis Pharmaceuticals Canada, Inc. from 2019 to 2022.
Mr. Warner completed undergraduate and MBAistration degrees at Northwood University (Michigan).
Aktive Positionen von Brent Warner
| Unternehmen | Position | Beginn |
|---|---|---|
Protego Biopharma, Inc.
Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Vorstandsvorsitzender | 01.04.2024 |
Ehemalige bekannte Positionen von Brent Warner
| Unternehmen | Position | Ende |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.04.2024 |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.02.2022 |
Ausbildung von Brent Warner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Northwood University (Michigan)
Northwood University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Protego Biopharma, Inc.
Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
















